BMS-663068 tris blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART).
Molecular Weight
704.62
Molecular Formula
C29H37N8O11P
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-663068 tris is examined for its enhanced stability and bioavailability compared to its parent compound in HIV treatment studies.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
